Axonics News

Wells Fargo Sticks to Its Hold Rating for Axonics Modulation Technologies (AXNX)

TipRanksApr 23 09:38 ET

RBC Capital Remains a Hold on Axonics Modulation Technologies (AXNX)

TipRanksApr 17 04:00 ET

Axonics Modulation Technologies (AXNX) Gets a Hold From Wells Fargo

TipRanksMar 22 06:29 ET

Axonics Modulation Technologies (AXNX) Gets a Hold From Wells Fargo

TipRanksMar 4 05:27 ET

Axonics Modulation Technologies (AXNX) Receives a Hold From Wells Fargo

TipRanksMar 1 05:00 ET

Axonics Analyst Ratings

BenzingaFeb 29 11:51 ET

Axonics Analyst Ratings

BenzingaJan 16 15:32 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Axonics Modulation Technologies (AXNX) and Siemens Healthineers AG (OtherSEMHF)

TipRanksJan 16 02:50 ET

Truist Securities Downgrades Axonics to Hold, Lowers Price Target to $71

BenzingaJan 12 15:29 ET

Axonics Analyst Ratings

BenzingaJan 12 15:28 ET

Piper Sandler Downgrades Axonics to Neutral From Overweight, Cuts Price Target to $71 From $75

MT NewswiresJan 12 08:45 ET

Leerink Partners Downgrades Axonics to Market Perform, Announces $71 Price Target

BenzingaJan 12 05:00 ET

Axonics Analyst Ratings

BenzingaJan 12 04:59 ET

Boston Scientific's Strategic Acquisition of Axonics: A Hold Rating Amidst Revenue Growth and EPS Impact Assessment

TipRanksJan 11 01:56 ET

Buy Rating Affirmed for Axonics Amid Strategic Acquisition by Boston Scientific

TipRanksJan 11 01:25 ET

Wells Fargo Downgrades Axonics to Equal-Weight, Raises Price Target to $71

BenzingaJan 10 06:50 ET

Axonics Analyst Ratings

BenzingaJan 10 06:49 ET

Axonics Analyst Ratings

BenzingaJan 9 07:22 ET

RBC Downgrades Axonics to Sector Perform From Outperform, Raises Price Target to $71 From $69 Amid Boston Scientific Deal

MT NewswiresJan 9 07:15 ET

Buy Rating Affirmed for Boston Scientific Following Strategic Axonics Acquisition

TipRanksJan 9 05:11 ET